there has been considerable inconsistency regarding the potential relationship between dyslipidemia and bone metabolism. the inflammatory stimulation through the receptor activator of the nuclear factor kappa-b ligand (rankl)/ receptor activator of the nuclear factor kappa-b (rank)/ osteoprotegerin (opg) pathway could be the infrastructural mechanism for hypercholesterolemia-induced bone loss. ...

The primary aim of this study was to investigate the status of RANKL6-7 gene polymorphism in patients with chronic (mild, moderate, severe) and aggressive periodontitis as well as healthy controls. We examined80 patients for the RANKL6-7 polymorphisms (rs1054016 and rs9567000). Polymorphism was determinedby polymerase chain reaction (PCR) followed by direct sequencing. No statistica...

Osteoclasts are induced by macrophage colony-stimulating factor-1 (CSF-1) and receptor activator of nuclear factor-?B (RANK) ligand (RANKL). Monocyte/macrophage lineages thought to be osteoclast precursors; however, such cells have not been fully characterized owing a lack tools for their identification. Osteoclast precursors express (CSF-1R) RANK. However, the capacity conventional methods usi...

background: receptor activator of nuclear factor kappa b ligand (rankl) is one of the key cytokines in the induction of osteoclastogenesis both in vitro and in vivo.several reports indicated the presence of srankl in gingival crevicular fluid of patients with periodontal diseases. objective: to determine the presence of rankl in peri-implant crevicular fluid samples of implants with peri-implan...

Tumor necrosis factor α (TNFα) is known to upregulate the expression of receptor activator of NF-κB ligand (RANKL). We investigated the role of the calcineurin/nuclear factor of activated T-cells (NFAT) signaling pathway in TNFα-induced RANKL expression in C2C12 and primary cultured mouse calvarial cells. TNFα-induced RANKL expression was blocked by the calcineurin/NFAT pathway inhibitors. TNFα...

RANKL is a type II membrane protein bearing close homology to TNFSF members TRAIL, FasL, and TNF-a. has been definite for its key characteristic role in bone metabolism the immune system. It an apoptosis regulator gene, binding partner of osteoprotegerin OPG, ligand receptor RANK, it controls cell proliferation by modifying levels. Osteoblasts stromal stem cells activator NFκ-B (RANKL), binds a...